中国天然药物
中國天然藥物
중국천연약물
CHINESE JOURNAL OF NATRUAL MEDICINES
2006年
5期
377-381
,共5页
全波%马百平%冯冰%熊呈琦%王永泽%康利平%张洁%阎浩林
全波%馬百平%馮冰%熊呈琦%王永澤%康利平%張潔%閻浩林
전파%마백평%풍빙%웅정기%왕영택%강리평%장길%염호림
生物转化%米曲霉%呋甾皂苷%次生呋甾皂苷%原薯蓣皂苷
生物轉化%米麯黴%呋甾皂苷%次生呋甾皂苷%原藷蕷皂苷
생물전화%미곡매%부치조감%차생부치조감%원서여조감
Biotransformation%Aspergillus oryzae%Furostanol saponin%Secondary furostanol saponin%Protodioscin
目的: 制备呋甾皂苷的生物转化产物.方法:利用米曲霉对原薯蓣皂苷(化合物1)进行转化,转化产物用大孔吸附树脂柱色谱,C18反相硅胶柱色谱,硅胶柱色谱以及高效液相色谱等进行分离纯化,通过光谱分析(FAB-MS,1H NMR,13C NMR)鉴定化学结构.结果:得到了5个转化产物,包括3个呋甾皂苷和2个螺甾皂苷.结论:米曲霉可以在保留原薯蓣皂苷的26-位葡萄糖的情况下水解3-位末端1→2鼠李糖生成次生呋甾皂苷(化合物4).米曲霉也可以去掉原薯蓣皂苷的22-位羟基生成20(22)双键的呋甾皂苷产物(化合物3和5),并且继续水解26-位葡萄糖生成相应的螺甾皂苷(化合物2和6).
目的: 製備呋甾皂苷的生物轉化產物.方法:利用米麯黴對原藷蕷皂苷(化閤物1)進行轉化,轉化產物用大孔吸附樹脂柱色譜,C18反相硅膠柱色譜,硅膠柱色譜以及高效液相色譜等進行分離純化,通過光譜分析(FAB-MS,1H NMR,13C NMR)鑒定化學結構.結果:得到瞭5箇轉化產物,包括3箇呋甾皂苷和2箇螺甾皂苷.結論:米麯黴可以在保留原藷蕷皂苷的26-位葡萄糖的情況下水解3-位末耑1→2鼠李糖生成次生呋甾皂苷(化閤物4).米麯黴也可以去掉原藷蕷皂苷的22-位羥基生成20(22)雙鍵的呋甾皂苷產物(化閤物3和5),併且繼續水解26-位葡萄糖生成相應的螺甾皂苷(化閤物2和6).
목적: 제비부치조감적생물전화산물.방법:이용미곡매대원서여조감(화합물1)진행전화,전화산물용대공흡부수지주색보,C18반상규효주색보,규효주색보이급고효액상색보등진행분리순화,통과광보분석(FAB-MS,1H NMR,13C NMR)감정화학결구.결과:득도료5개전화산물,포괄3개부치조감화2개라치조감.결론:미곡매가이재보류원서여조감적26-위포도당적정황하수해3-위말단1→2서리당생성차생부치조감(화합물4).미곡매야가이거도원서여조감적22-위간기생성20(22)쌍건적부치조감산물(화합물3화5),병차계속수해26-위포도당생성상응적라치조감(화합물2화6).
AIM: To prepare biotransformation products of furostanol saponin. METHOD: Protodioscin (compound 1) was biotransformed by Aspergillus oryzae and the products were purified by column chromatography of macroporous absorbent resin and reverse phase C18 and high performance liquid chromatography. The structures of products were ascertained by FAB-MS, 1H NMR and 13C NMR. RESULT: Biotransformation of protodioscin led to five main bioconversion products including three furostanol saponins and two spirostanol saponins. CONCLUSION: It has been found that Aspergillus oryzae is able to hydrolyze the terminal rhamnopyranosyl residue with 1→2 linkage to sugar chain of protodioscin at C-3 position, while retaining glucopyranosyl residue at C-26 position to produce secondary furostanol saponin (compound 4). Aspergillus oryzae also can abscise the hydroxyl at C-22 position of furostanol saponins to produce furostanol saponins (compounds 3 and 5), which have ethylenic linkage between C-20 and C-22 position, and hydrolyze the glucopyranosyl residue of furostanol saponins at C-26 position to produce corresponding spirostanol saponins (compounds 2 and 6).